v3.26.1
Stock-Based Compensation (Tables)
6 Months Ended
Jun. 30, 2026
Stock-Based Compensation  
Schedule of stock option activity and related information

  ​ ​ ​

Number of Shares

  ​ ​ ​

Weighted - Average Exercise Price

  ​ ​ ​

Weighted-Average Remaining Contractual Term (in years)

  ​ ​ ​

Aggregate Intrinsic Value
(in thousands)

Outstanding - December 31, 2025

10,675,615

$

13.46

8.60

$

243,979

Granted

2,299,700

$

19.35

Exercised

(103,592)

$

11.33

$

1,204

Forfeited or cancelled

(226,323)

$

13.76

Outstanding - June 30, 2026

12,645,400

$

14.54

8.26

$

139,386

Options vested and exercisable as of June 30, 2026

4,796,080

$

12.35

7.50

$

62,478

Options vested and expected to vest as of June 30, 2026

12,645,400

$

14.54

8.26

$

139,386

Summary of company's RSU activity

  ​ ​ ​

Number of Shares

  ​ ​ ​

Weighted - Average Grant Date Fair Value

Unvested as of December 31, 2025

599,675

$

14.23

Granted

848,100

$

19.49

Vested

(119,545)

$

11.94

Forfeited

(64,536)

$

12.81

Unvested as of June 30, 2026

1,263,694

$

18.05

Schedule of stock-based compensation expense as reflected in consolidated statements of operations

The Company recognized stock-based compensation expense related to the issuance of equity awards to employees and directors in the unaudited condensed consolidated statement of operations as follows (in thousands):

Three Months Ended June 30,

Six Months Ended June 30,

2026

2025

2026

2025

Research and development

$

3,861

$

2,113

$

6,957

3,694

General and administrative

4,758

3,932

10,857

7,737

Total stock-based compensation expense

$

8,619

$

6,045

$

17,814

$

11,431